Capital Raising & Corporate Finance
Pharmaceutical Giant Sees Largest-Ever Bond Sale
Pfizer’s eight tranches of notes, priced from $3 billion to $6 billion each, will mature between 2025 and 2063.
Capital Raising & Corporate Finance
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
Capital Raising & Corporate Finance
Qantas’ First Female CEO Readies For Bumpy Ride
Qantas’ new CEOVanessaHudsonhas spanned roles both onshore and offshore across the commercial, customer and finance segments of the company.
Capital Raising & Corporate Finance
Pfizer’s $43B Pursuit Of Seagen: Q&A With Séverine Piot-Deval
Pfizer’s $31 billion bond sale to fund its $43 billion acquisition of cancer drug maker Seagen is one of the largest in history. Healthcare expert Severine Piot-Deval discusses the deal with Global Finance.
Capital Raising & Corporate Finance
CFO Corner: Q&A With Lamborghini’s Paolo Poma
Automobili Lamborghini's CFO Paolo Poma explains to Global Finance how his unusual career path from engineering to the C-suite prepared him to lead the company in an era of tighter credit conditions.
Capital Raising & Corporate Finance
EY Scraps Breakup Plans—For Now
EY's plan to separate its auditing and consulting businesses from one another toaddress conflict of interest concerns comes to naught.
Capital Raising & Corporate Finance
HSBC’s Future Is On The Line
Ping An Insurance of China, one of the world’s biggest insurers and a major HSBC stakeholder, has been pushing for a break-up of the Group’s Asian and UK operations.
Capital Raising & Corporate Finance
Private Equity’s Dry Powder
PE firms are attempting to navigate a barren M&A landscape, with trillions in capital ready to deploy. But where?
Features
Softbank Continues Arm Wrestle
To help beef up Arm’s potential earnings ahead of anIPO, Softbank appears to be tinkering with Arm’s unique selling point.
Capital Raising & Corporate Finance
CFOs Wanted: Startups Lack Strong Financial Hands
Many startups were unableto access their funds during SVB's demise in part because they lacked CFOs.
Capital Raising & Corporate Finance
China: IPOs Surge Under New Listing Rules
The new rules—which debuted in Shanghai and Shenzhen last month—are aimed at speeding up listings and boosting corporate fund-raising.
Banking
Credit Suisse Battles $160 Million Fraud Trial
This credit-crisis legacy issue sits among the raft of allegations of fraud and other misconduct surrounding Credit Suisse’s descent into cultural failure, which UBS management claims it will now be rooting out.
Capital Raising & Corporate Finance
Nigerian Banks Adopt Holding Company Structures
Shifting to a holding company allows the parent company to coordinate and manage all the units.